Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Mitotane is a drug specifically designed to treat adrenocortical carcinoma (ACC) and its metastases, and it is also indicated for the treatment of hypercortisolism (also known as C···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：274
Mitotane is mainly used for the treatment of adrenocortical carcinoma (ACC) and its migratory carcinoma, and can also be used for adrenal hyperplasia or hypercortisolism caused by ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：186
Selpercatinib is a targeted therapy drug that is mainly used to inhibit cancer caused by mutations in the RET gene. It has shown remarkable efficacy in controlling the spread of ca···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：268
As a targeted drug targeting RET mutations, Selpercatinib can block the signaling pathway of tumors, and has performed well in the treatment of advanced or metastatic cancers, maki···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：224
Serpatinib interferes with the growth signal of cancer cells by selectively inhibiting RET kinase. It is suitable for a variety of RET gene-related cancer types, such as medullary ···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：297
As a RET gene-targeted drug, Selpercatinib can effectively treat RET-related cancers; By inhibiting key signaling pathways, it inhibits the spread and invasion of cancer cells. It ···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：230
Serpatinib is an innovative cancer treatment that targets mutations in the RET gene and reduces the growth and division of tumor cells by inhibiting specific kinases. It is especia···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：247
Selpercatinib has a significant effect on RET-mutated cancers, especially in the treatment of non-small cell lung cancer. It stops tumor development by interfering with the signali···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：225
Mitotane is a synthetic chlorinated alkyl compound, the chemical name is 1,1-dichloro-2-(O-chlorophenyl)-2-(p-chlorophenyl)ethane. It works mainly by interfering with the normal ph···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：188
Mitotane is a targeted drug that is mainly used to treat adrenocortical carcinoma and its related conditions.What is Mitotane?As a specific drug, the mechanism of action of Mitotan···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：204
Selpercatinib is a targeted therapy drug that is specifically used for cancers associated with the RET gene. It reduces the spread of cancer cells by inhibiting RET kinase. It is s···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：219
As a highly selective RET inhibitor, Selpercatinib can effectively block the RET signaling pathway. It is primarily used for the treatment of RET fusion-positive solid tumors. Pati···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：237
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3672024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：802025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：932025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
